Aviva PLC Corcept Therapeutics Inc Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Aviva PLC holds 17,327 shares of CORT stock, worth $996,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,327

Previous 21,220 18.35%

Holding current value

$996,995

Previous $689,000 16.26%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $114,882 - $180,090	-3,893 Reduced 18.35%	17,327 $801,000
Q2 2024 Aug 02, 2024	SELL	$22.21 - $34.48 $116,935 - $181,537	-5,265 Reduced 19.88%	21,220 $689,000
Q1 2024 May 14, 2024	BUY	$21.1 - $27.46 $85,919 - $111,817	4,072 Added 18.17%	26,485 $667,000
Q4 2023 Feb 09, 2024	BUY	$24.82 - $32.88 $556,290 - $736,939	22,413 New	22,413 $727,000
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $2.11 Million - $3.22 Million	-127,855 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$17.1 - $23.34 $834,616 - $1.14 Million	48,808 Added 61.75%	127,855 $2.53 Million
Q3 2021 Nov 12, 2021	BUY	$19.68 - $22.53 $1.56 Million - $1.78 Million	79,047 New	79,047 $1.56 Million
Q1 2021 May 13, 2021	SELL	$23.49 - $30.56 $1.66 Million - $2.16 Million	-70,676 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$16.78 - $27.3 $961,443 - $1.56 Million	-57,297 Reduced 44.77%	70,676 $1.85 Million
Q3 2020 Nov 12, 2020	SELL	$12.46 - $19.98 $104,364 - $167,352	-8,376 Reduced 6.14%	127,973 $2.23 Million
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $1.99 Million - $3.3 Million	-180,494 Reduced 56.97%	136,349 $2.29 Million
Q1 2020 May 14, 2020	BUY	$10.11 - $14.04 $3.2 Million - $4.45 Million	316,843 New	316,843 $3.77 Million

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account